$736 Million is the total value of Soleus Capital Management, L.P.'s 76 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 52.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $49,175,000 | -29.4% | 234,859 | -20.5% | 6.68% | -38.5% |
| ISEE | Buy | IVERIC BIO INC | $44,897,000 | +410.4% | 2,502,601 | +173.7% | 6.10% | +344.6% |
| EDAP | Buy | EDAP TMS S Asponsored adr | $40,340,000 | +80.6% | 4,889,745 | +48.9% | 5.48% | +57.3% |
| SKIN | Sell | THE BEAUTY HEALTH COMPANY | $31,431,000 | -25.4% | 2,665,876 | -18.6% | 4.27% | -35.0% |
| ILMN | New | ILLUMINA INC | $28,924,000 | – | 151,600 | +100.0% | 3.93% | – |
| CVS | Buy | CVS HEALTH CORP | $27,266,000 | +34.1% | 285,900 | +30.3% | 3.70% | +16.8% |
| BCAB | Buy | BIOATLA INC | $26,184,000 | +181.6% | 3,400,503 | +4.2% | 3.56% | +145.2% |
| LLY | New | LILLY ELI & CO | $26,127,000 | – | 80,800 | +100.0% | 3.55% | – |
| CRL | New | CHARLES RIV LABS INTL INC | $25,407,000 | – | 129,100 | +100.0% | 3.45% | – |
| SRDX | Buy | SURMODICS INC | $23,362,000 | -5.1% | 768,478 | +16.3% | 3.17% | -17.3% |
| Buy | ARCELLX INC | $23,273,000 | +41.5% | 1,239,913 | +36.3% | 3.16% | +23.2% | |
| ORGO | Buy | ORGANOGENESIS HLDGS INC | $21,025,000 | -18.5% | 6,489,063 | +22.8% | 2.86% | -29.0% |
| IRMD | Buy | IRADIMED CORP | $20,582,000 | -2.3% | 684,690 | +10.3% | 2.80% | -14.9% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $19,867,000 | +82.6% | 415,200 | +125.9% | 2.70% | +59.0% |
| THTX | Buy | THERATECHNOLOGIES INC | $18,978,000 | +6.9% | 8,007,714 | +2.4% | 2.58% | -6.9% |
| NVST | New | ENVISTA HOLDINGS CORPORATION | $15,749,000 | – | 480,000 | +100.0% | 2.14% | – |
| KRYS | Sell | KRYSTAL BIOTECH INC | $14,451,000 | +2.6% | 207,332 | -3.3% | 1.96% | -10.6% |
| CCCC | Buy | C4 THERAPEUTICS INC | $12,642,000 | +493.2% | 1,441,513 | +410.0% | 1.72% | +417.5% |
| New | AMYLYX PHARMACEUTICALS INC | $12,086,000 | – | 429,336 | +100.0% | 1.64% | – | |
| NTRA | Buy | NATERA INC | $12,080,000 | +158.5% | 275,673 | +109.0% | 1.64% | +125.1% |
| INSP | Sell | INSPIRE MED SYS INC | $11,955,000 | -26.4% | 67,400 | -24.2% | 1.62% | -35.9% |
| CUTR | Sell | CUTERA INC | $11,664,000 | +20.7% | 255,792 | -0.7% | 1.58% | +5.2% |
| Sell | DICE THERAPEUTICS INC | $10,857,000 | -14.2% | 535,358 | -34.4% | 1.48% | -25.3% | |
| CVRX | CVRX INC | $9,881,000 | +55.2% | 1,059,040 | 0.0% | 1.34% | +35.2% | |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $9,821,000 | +23.6% | 1,025,200 | +42.5% | 1.33% | +7.7% |
| NPCE | NEUROPACE INC | $8,753,000 | -24.2% | 2,334,003 | 0.0% | 1.19% | -34.0% | |
| VCEL | New | VERICEL CORP | $8,677,000 | – | 374,000 | +100.0% | 1.18% | – |
| PCVX | Sell | VAXCYTE INC | $8,056,000 | -0.1% | 335,650 | -9.4% | 1.10% | -13.0% |
| CSTL | New | CASTLE BIOSCIENCES INC | $7,768,000 | – | 297,840 | +100.0% | 1.06% | – |
| NARI | Buy | INARI MED INC | $7,381,000 | +50.1% | 101,608 | +40.5% | 1.00% | +30.8% |
| TMDX | Sell | TRANSMEDICS GROUP INC | $7,317,000 | +26.1% | 175,300 | -5.0% | 0.99% | +9.8% |
| HUM | New | HUMANA INC | $6,890,000 | – | 14,200 | +100.0% | 0.94% | – |
| NRIX | Sell | NURIX THERAPEUTICS INC | $6,569,000 | -47.9% | 504,144 | -49.3% | 0.89% | -54.6% |
| INBX | New | INHIBRX INC | $6,532,000 | – | 363,902 | +100.0% | 0.89% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $6,523,000 | – | 34,800 | +100.0% | 0.89% | – |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $6,381,000 | +35.0% | 123,014 | +23.0% | 0.87% | +17.6% |
| APEN | Sell | APOLLO ENDOSURGERY INC | $6,265,000 | -47.5% | 1,137,105 | -65.2% | 0.85% | -54.3% |
| BIIB | New | BIOGEN INC | $6,194,000 | – | 23,200 | +100.0% | 0.84% | – |
| KROS | New | KEROS THERAPEUTICS INC | $5,493,000 | – | 146,000 | +100.0% | 0.75% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $5,404,000 | +84.3% | 27,000 | +34.3% | 0.73% | +60.6% |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $5,308,000 | – | 5,587,789 | +100.0% | 0.72% | – |
| AXGN | New | AXOGEN INC | $5,066,000 | – | 424,998 | +100.0% | 0.69% | – |
| EPIX | Sell | ESSA PHARMA INC | $4,806,000 | -63.4% | 2,640,539 | -36.7% | 0.65% | -68.1% |
| PIRS | PIERIS PHARMACEUTICALS INC | $4,755,000 | -38.5% | 4,134,868 | 0.0% | 0.65% | -46.4% | |
| New | ENOVIS CORPORATION | $4,704,000 | – | 102,100 | +100.0% | 0.64% | – | |
| EXAS | Buy | EXACT SCIENCES CORP | $4,705,000 | +0.4% | 144,800 | +21.7% | 0.64% | -12.6% |
| CELC | Buy | CELCUITY INC | $4,457,000 | +16.9% | 443,912 | +6.0% | 0.61% | +1.8% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $3,494,000 | +53.1% | 96,800 | +29.1% | 0.48% | +33.4% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $3,420,000 | -19.8% | 62,620 | -20.1% | 0.46% | -30.1% |
| NVRO | New | NEVRO CORP | $3,355,000 | – | 72,000 | +100.0% | 0.46% | – |
| New | IMAGO BIOSCIENCES INC | $3,206,000 | – | 213,000 | +100.0% | 0.44% | – | |
| FGEN | Sell | FIBROGEN INC | $3,045,000 | -4.6% | 234,026 | -22.6% | 0.41% | -16.9% |
| LYRA | LYRA THERAPEUTICS INC | $2,968,000 | -11.3% | 592,417 | 0.0% | 0.40% | -22.8% | |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $2,849,000 | -25.3% | 135,618 | -30.8% | 0.39% | -35.0% |
| OSUR | New | ORASURE TECHNOLOGIES INC | $2,141,000 | – | 565,000 | +100.0% | 0.29% | – |
| INMD | Sell | INMODE LTD | $1,963,000 | -53.3% | 67,449 | -64.0% | 0.27% | -59.2% |
| DXCM | Sell | DEXCOM INC | $1,920,000 | -45.5% | 23,836 | -49.5% | 0.26% | -52.5% |
| ETNB | New | 89BIO INC | $1,911,000 | – | 330,000 | +100.0% | 0.26% | – |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $1,649,000 | -69.1% | 219,000 | -74.1% | 0.22% | -73.0% |
| ANAB | Sell | ANAPTYSBIO INC | $1,633,000 | -87.5% | 64,027 | -90.1% | 0.22% | -89.1% |
| KDNY | Sell | CHINOOK THERAPEUTICS INC | $1,533,000 | -0.4% | 78,000 | -11.4% | 0.21% | -13.3% |
| FATE | Sell | FATE THERAPEUTICS INC | $1,508,000 | -68.7% | 67,300 | -65.4% | 0.20% | -72.7% |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $1,438,000 | +7.6% | 22,000 | 0.0% | 0.20% | -6.7% | |
| NVO | New | NOVO-NORDISK A Sadr | $1,405,000 | – | 14,100 | +100.0% | 0.19% | – |
| VSTM | VERASTEM INC | $1,398,000 | -26.7% | 1,644,500 | 0.0% | 0.19% | -36.2% | |
| XILIO THERAPEUTICS INC | $1,320,000 | -0.4% | 453,660 | 0.0% | 0.18% | -13.5% | ||
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $1,257,000 | -39.0% | 87,182 | -36.0% | 0.17% | -46.7% |
| Sell | PEPGEN INC | $1,180,000 | -32.1% | 130,000 | -25.7% | 0.16% | -41.0% | |
| BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $1,157,000 | +8.3% | 1,950,000 | 0.0% | 0.16% | -6.0% | ||
| APLS | New | APELLIS PHARMACEUTICALS INC | $915,000 | – | 13,400 | +100.0% | 0.12% | – |
| Sell | IO BIOTECH INC | $781,000 | -74.5% | 288,119 | -56.0% | 0.11% | -77.8% | |
| IMUX | IMMUNIC INC | $758,000 | -9.0% | 240,000 | 0.0% | 0.10% | -20.8% | |
| DA32 LIFE SCNCE TEC ACQSTN C | $487,000 | +0.4% | 50,000 | 0.0% | 0.07% | -13.2% | ||
| PLRX | Sell | PLIANT THERAPEUTICS INC | $443,000 | -88.7% | 21,200 | -95.7% | 0.06% | -90.2% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $404,000 | -90.8% | 25,300 | -92.0% | 0.06% | -91.9% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $400,000 | -95.9% | 19,518 | -97.7% | 0.05% | -96.4% |
| VTGN | Exit | VISTAGEN THERAPEUTICS INC | $0 | – | -825,000 | -100.0% | -0.11% | – |
| NVCR | Exit | NOVOCURE LTD | $0 | – | -13,275 | -100.0% | -0.14% | – |
| OM | Exit | OUTSET MED INC | $0 | – | -69,200 | -100.0% | -0.16% | – |
| CGEM | Exit | CULLINAN ONCOLOGY INC | $0 | – | -95,485 | -100.0% | -0.19% | – |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -252,000 | -100.0% | -0.32% | – |
| LNTH | Exit | LANTHEUS HLDGS INC | $0 | – | -55,222 | -100.0% | -0.57% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -154,400 | -100.0% | -0.60% | – |
| STAA | Exit | STAAR SURGICAL CO | $0 | – | -75,094 | -100.0% | -0.83% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -79,700 | -100.0% | -0.94% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -77,842 | -100.0% | -0.97% | – |
| SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -258,100 | -100.0% | -1.16% | – |
| STE | Exit | STERIS PLC | $0 | – | -37,310 | -100.0% | -1.20% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -68,800 | -100.0% | -1.34% | – |
| EOLS | Exit | EVOLUS INC | $0 | – | -810,676 | -100.0% | -1.47% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -169,696 | -100.0% | -1.75% | – |
| ANGO | Exit | ANGIODYNAMICS INC | $0 | – | -670,000 | -100.0% | -2.02% | – |
| SKIN | Exit | THE BEAUTY HEALTH COMPANYcall | $0 | – | -1,300,000 | -100.0% | -2.61% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.